168 related articles for article (PubMed ID: 27465799)
1. Negative prognostic impact of low absolute CD4
Zhang XY; Xu J; Zhu HY; Wang Y; Wang L; Fan L; Wu YJ; Li JY; Xu W
Cancer Sci; 2016 Oct; 107(10):1471-1476. PubMed ID: 27465799
[TBL] [Abstract][Full Text] [Related]
2. Low absolute NK cell counts in peripheral blood are associated with inferior survival in patients with mantle cell lymphoma.
Zhou XH; Zhang XY; Liang JH; Zhu HY; Wang L; Xia Y; Cao L; Wu W; Fan L; Li JY; Xu W
Cancer Biomark; 2019; 24(4):439-447. PubMed ID: 30932881
[TBL] [Abstract][Full Text] [Related]
3. T-cell levels are prognostic in mantle cell lymphoma.
Nygren L; Wasik AM; Baumgartner-Wennerholm S; Jeppsson-Ahlberg Å; Klimkowska M; Andersson P; Buhrkuhl D; Christensson B; Kimby E; Wahlin BE; Sander B
Clin Cancer Res; 2014 Dec; 20(23):6096-104. PubMed ID: 25294911
[TBL] [Abstract][Full Text] [Related]
4. Low absolute CD4
He L; Liang JH; Wu JZ; Li Y; Qin SC; Miao Y; Wu YJ; Wang Y; Wang L; Fan L; Li JY; Xu W
Tumour Biol; 2016 Sep; 37(9):12589-12595. PubMed ID: 27388165
[TBL] [Abstract][Full Text] [Related]
5. Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy.
Zhang YP; Zhang R; Zhu HY; Wang L; Wu YJ; Liang JH; Shi WY; Liu H; Xu W; Li JY
Cancer Res Treat; 2019 Jan; 51(1):368-377. PubMed ID: 29764116
[TBL] [Abstract][Full Text] [Related]
6. Low absolute CD4
Zeng R; Zhu W; Jiang L; Zhu X; Gao Y; Xia Y; Bai B; Shikama N; Janetos TM; Dalia S; Alpdogan O; Wang X; Zhu L; Li P
Ann Transl Med; 2022 Oct; 10(20):1119. PubMed ID: 36388826
[TBL] [Abstract][Full Text] [Related]
7. Can the prognosis of mantle cell lymphoma be predicted by simple CBC counts?
Haydaroglu Sahin H
Medicine (Baltimore); 2019 Jul; 98(30):e16180. PubMed ID: 31348229
[TBL] [Abstract][Full Text] [Related]
8. Circulating low CD4
Cao X; Kong YL; Wang L; Liang JH; Xia Y; Zhu HY; Fan L; Jiang SH; Liu H; Li JY; Xu W
Ann Hematol; 2021 Apr; 100(4):995-1002. PubMed ID: 33651193
[TBL] [Abstract][Full Text] [Related]
9. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma.
Yoo C; Yoon DH; Kim S; Huh J; Park CS; Park CJ; Lee SW; Suh C
Hematol Oncol; 2016 Mar; 34(1):22-7. PubMed ID: 25689467
[TBL] [Abstract][Full Text] [Related]
10. [Clinical Significance of Detecting CD4
Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of Peripheral Blood T Lymphocyte Subsets with Prognosis of Elderly Patients with Newly Diagnosed Multiple Myeloma].
Ding J; Gu Y; Zhao SS; Wu YJ; Shi QL; Qu XY; Li JY; Chen LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1876-1880. PubMed ID: 31839053
[TBL] [Abstract][Full Text] [Related]
12. Low absolute CD4
Gu Y; Jin Y; Ding J; Yujie W; Shi Q; Qu X; Zhao S; Li J; Lijuan C
Leuk Lymphoma; 2020 Aug; 61(8):1869-1876. PubMed ID: 32324088
[TBL] [Abstract][Full Text] [Related]
13. Low Level of Blood CD4
Judd J; Dulaimi E; Li T; Millenson MM; Borghaei H; Smith MR; Al-Saleem T
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):83-88. PubMed ID: 28027895
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
[TBL] [Abstract][Full Text] [Related]
15. Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy.
Junlén HR; Lockmer S; Kimby E; Wahlin BE
Ann Hematol; 2020 Oct; 99(10):2357-2366. PubMed ID: 32808106
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database.
Salek D; Vesela P; Boudova L; Janikova A; Klener P; Vokurka S; Jankovska M; Pytlik R; Belada D; Pirnos J; Moulis M; Kodet R; Michal M; Janousova E; Muzik J; Mayer J; Trněný M
Leuk Lymphoma; 2014 Apr; 55(4):802-10. PubMed ID: 23772666
[TBL] [Abstract][Full Text] [Related]
17. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of monocyte count at presentation in mantle cell lymphoma.
von Hohenstaufen KA; Conconi A; de Campos CP; Franceschetti S; Bertoni F; Margiotta Casaluci G; Stathis A; Ghielmini M; Stussi G; Cavalli F; Gaidano G; Zucca E
Br J Haematol; 2013 Aug; 162(4):465-73. PubMed ID: 23808798
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.
Plonquet A; Haioun C; Jais JP; Debard AL; Salles G; Bene MC; Feugier P; Rabian C; Casasnovas O; Labalette M; Kuhlein E; Farcet JP; Emile JF; Gisselbrecht C; Delfau-Larue MH;
Ann Oncol; 2007 Jul; 18(7):1209-15. PubMed ID: 17496307
[TBL] [Abstract][Full Text] [Related]
20. Mantle cell lymphoma: a Turkish Multi-Center Study.
Okay M; Meletli O; Kelkitli E; Malkan UY; Turgut M; Buyukasik Y; Tekin F; Demiroglu H; Goker H
J BUON; 2019; 24(5):2084-2089. PubMed ID: 31786879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
